Authors: GREGG RWC KAIZER L FINE S GELMON K WIELGOSZ G EISENHAUER E

Citation: Rwc. Gregg et al., A PHASE-II TRIAL OF DUP-937 (TELOXANTRONE) IN NON-SMALL-CELL LUNG-CANCER - A STUDY OF THE NCIC CLINICAL-TRIALS GROUP, Annals of oncology, 4(8), 1993, pp. 693-694

Authors: SHORE T EISENHAUER E QUIRT I BELANGER K LOHMANN R SILVER H WIELGOSZ G

Citation: T. Shore et al., A PHASE-II STUDY OF DUP-937 (TELOXANTRONE) IN METASTATIC MALIGNANT-MELANOMA - A STUDY OF THE NATIONAL-CANCER-INSTITUTE-OF-CANADA CLINICAL-TRIALS GROUP (NCICCTG), Annals of oncology, 4(8), 1993, pp. 695-696

Authors: MAROUN JA SKILLINGS J MACCORMICK R POTVIN M WIELGOSZ G DAVIDSON JR EISENHAUER E

Citation: Ja. Maroun et al., PHASE-II STUDY ON DUP-937 (TELOXANTRONE) IN COLORECTAL-CARCINOMA - A CANADIAN-NATIONAL-CANCER-INSTITUTE CLINICAL-TRIAL GROUP-STUDY, Investigational new drugs, 11(2-3), 1993, pp. 235-237